Autobacs Seven Co., Ltd.'s next confirmed earnings release is scheduled for October 30, 2026.
| Earnings Date | 10/30/2026 |
As of March 31, 2026, Autobacs Seven Co., Ltd. has 78.53M shares outstanding.
| Shares Outstanding | 78.53M |
As of March 31, 2026, Autobacs Seven Co., Ltd. maintains a current ratio of 1.96, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.96 |
| Quick Ratio | 0.38 |
| Debt / Equity | 30.24 |
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 5,305.00 |
As of March 31, 2026, Autobacs Seven Co., Ltd. holds 127.79M in cash and equivalents against 225.22M in total debt, resulting in a net debt position of 100.20M. Total book value stands at 742.77M, with working capital of 326.03M providing operational flexibility.
| Cash & Cash Equivalents | 127.79M |
| Total Debt | 225.22M |
| Net Debt | 100.20M |
| Equity (Book Value) | 742.77M |
| Book Value Per Share | 9.46 |
| Working Capital | 326.03M |
Autobacs Seven Co., Ltd.'s most recent stock split took place on March 27, 2013 with a 1:3 split ratio.
| Last Split Date | 3/27/2013 |
| Split Ratio | 1:3 |
Already premium?